RxDoctor Payments Data

Matthew Moreland, DO

Family Medicine · Midlothian, TXNPI 1083681381

Payments from drug & device makers

$992in general payments, 2019–2025

Across 60 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$250
  • Pfizer$106
  • AbbVie$105
  • AstraZeneca$77
  • Amgen$68
  • Lilly USA, LLC$60
  • plus $327 from 17 others

What the payments were for

  • Food & beverage$98199%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$992 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$30,281
Medicare patients
82
Services billed
553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$37,886
EliquisApixaban34$36,470
MounjaroTirzepatide23$35,058
JardianceEmpagliflozin17$21,915
MyrbetriqMirabegron26$13,775
LinzessLinaclotide16$11,531
FarxigaDapagliflozin Propanediol12$10,425
Tresiba Flextouch U-200Insulin Degludec11$6,539
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$2,163
Potassium Chloride65$1,478
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,344
Levothyroxine Sodium140$1,302
Pantoprazole Sodium122$1,256
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine32$1,177
Bupropion XlBupropion Hcl31$1,140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$250$37,88645 claims
PfizerEliquis$106$36,47034 claims
Lilly USA, LLCMounjaro, Olanzapine$60$35,48147 claims
Astellas Pharma US IncMyrbetriq$21$13,77526 claims
AbbVieLinzess$105$11,53116 claims
AstraZenecaFarxiga$77$10,42512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Midlothian

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →